Prone Transpsoas Fusion for Grade I - II Symptomatic Degenerative Spondylolisthesis - Prospective Cohort Study of 108 Patients

俯卧位经腰大肌融合术治疗I-II级症状性退行性脊椎滑脱症——108例患者的前瞻性队列研究

阅读:1

Abstract

Study DesignProspective Cohort Study of 108 cases.ObjectiveProne Transpsoas (PTP) fusion is a minimally invasive surgical technique using a single-position prone lateral approach to augment the anterior column of the lumbar spine. Degenerative spondylolisthesis (DS) is a common pathology where anterior-posterior access can be advantageous. This study aimed to evaluate operative, radiological and functional outcomes of PTP fusion in the management of symptomatic DS.MethodsA multi-centre cohort study was conducted, involving 108 consecutive patients who underwent PTP fusion for low-grade (Grade I-II) DS. Descriptive statistical analysis was used to evaluate clinical, radiological and functional outcomes.ResultsIn all 108 cases, anterior column fusion was combined with posterior percutaneous pedicle screw fixation to optimise spinal realignment. The cohort's average operative time was 115 minutes, and the psoas retraction time was 14 minutes. The cohort had an average slip of 5.9 mm, which was reduced to 0.8 mm (P < 0.001) postoperatively. Statistically significant radiological improvements were observed in lumbar lordosis (Δ5°), segmental lordosis (Δ4°), anterior disc height (Δ 4.2 mm) and posterior disc height (Δ 2.1 mm). No major vascular or visceral complications were encountered. The sustained neurological complication rate was 1.9%, and patients maintained improved functional outcomes through the 1-year follow-up.ConclusionsPTP is a safe approach for managing low-grade DS, showing significant postoperative correction of spinal alignment. These results support the use of PTP fusion for treating spondylolisthesis and add to the growing evidence of its safety and efficacy as a minimally invasive technique.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。